Mentice launches Ankyras in Brazil
Mentice has officially launched its treatment planning solution, Ankyras, in Brazil after receiving regulatory clearance from ANVISA, Brazil’s National Health Surveillance Agency. According to the company, this marks a significant advancement of intracranial aneurysm care in Latin America, enabling physicians to leverage virtual rehearsal and patient-specific simulation to improve clinical outcomes.
Ankyras is a clinical decision-support application for flow diverter planning in neurointervention. It leverages patient-specific anatomical modelling based on 3D rotational angiography (3DRA) or magnetic resonance angiography (MRA) images to optimise device selection and positioning.
Expanding to leading neurovascular treatment market in Latin America
Following a successful European launch, the Ankyras platform is now also available for clinical use in Brazil.
Brazil accounts for over 60 per cent of all neurovascular procedures in Latin America, underscoring its strategic importance in the region. Brazil’s intracranial aneurysm treatment market is projected to reach USD 86.5 million by 2030. The launch of Ankyras further solidifies Brazil’s pivotal role in advancing neurovascular care.
– Bringing Ankyras to Brazil with ANVISA represents a major achievement for Mentice and a significant advancement for neurointerventional practice in Latin America, says Laura Obradó, Project Manager Ankyras at Mentice.
– We are excited to provide Brazilian physicians with a validated, patient-specific solution that enhances precision, efficiency, and clinical outcomes in the treatment of intracranial aneurysms.
Clinical-decision support
The Ankyras application has been designed to support physicians in selecting a suitable flow diverter for treating intracranial aneurysms. According to Mentice’s internal clinical validation data submitted for CE and FDA purposes, Ankyras predicts the device foreshortening (reduction in length) for patient-specific aneurysm treatment planning with 94 per cent average accuracy.
In Brazil, the physicians are able to upload their own cases to Mentice’s VIST simulation platform and rehearse procedures in a virtual environment. This practice is already well established through Mentice’s collaboration with the Brazilian Society of Neuroradiology (SBNR).
– By making streamlined, patient-specific aneurysm treatment planning more widely available, we are supporting Interventional Neuroradiologists make faster, more informed decisions, and now even rehearse their cases in the virtual environment using VIST to ultimately improve patient outcomes, says Laura Obradó.
Mentice will partner with leading Brazilian institutions to deliver training, onboarding, and clinical support – ensuring a seamless rollout of Ankyras across the region.
Innehållet i BioStocks nyheter och analyser är oberoende men BioStocks verksamhet är i viss mån finansierad av bolag i branschen. Detta inlägg avser ett bolag som BioStock erhållit finansiering från.
